In vivo (mouse), in vitro (cell culture) and ex vivo (human tissue and plasma), we identified miR-24 as a key regulator of AAA initiation and propagation, which acts in part by targeting CHI3L1 (Supplementary Fig. 9). The gene discussed is CHI3L1; the disease is triple-A syndrome.